FDA inspection
Grifols Therapeutics LLC: FDA inspection ending Sep 1, 2023
FDA inspection 1221101 · Voluntary Action Indicated (VAI) · Clayton, NC
Key facts
| Inspection ID | 1221101 |
|---|---|
| Firm | Grifols Therapeutics LLC |
| FEI number | 1050373 |
| Address | 8368 Us 70 Bus Hwy W |
| City | Clayton |
| State | NC |
| ZIP | 27520-9464 |
| Fiscal year | 2023 |
| Inspection end date | Sep 1, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data